In this episode of Causes or Cures, Dr. Eeks chats with Jack Swain, head of clinical operations at Mindbloom. Mindbloom is a mental health and wellness company dedicated to expanding science-based treatments for depression and anxiety, and they are starting with at-home, sublingual Ketamine treatment that is supplemented with telehealth and peer support.
There is an explosion of interest in how psychedelics and other kinds of alternatives might be used to treat depression and anxiety, diseases that are notoriously difficult to treat, particularly for the long-term. In this episode, Jack will discuss a recent study involving Mindbloom that was published in the Journal of Affective Disorders in October'22. He will discuss what Ketamine is, the theory for why it helps with depression and anxiety, and Ketamine's disassociation effect. He breaks down the "methods" section of the research (what the outcomes were, how they were measured and how the study was set up) and the results of the study. He talks any safety or side effect concerns with Ketamine and finally, the benefits of sublingual (under-the-tongue) Ketamine vs IV Ketamine. He'll also touch on what else is in store for Mindbloom.
You can contact Dr. Eeks at bloomingwellness.com.
Follow Dr. Eeks on Instagram here.
Or Facebook here.
Subcribe to her newsletter here!